Skip to main content
. Author manuscript; available in PMC: 2016 Jul 28.
Published in final edited form as: Pharm Pat Anal. 2012 May;1(2):145–163. doi: 10.4155/ppa.12.17
101. Merck WO112217 (2008).
102. Merc k & Co. Inc. WO145957 (2007).
103. Merck WO155156 (2009).
104. Merck WO156726 (2008).
105. Merck WO011375 (2010).
106. Merck WO075830 (2009).
107. Merck WO 2010000364 (2010)
108. Merck WO076316 (2011).
109. Merck WO076327 (2011).
110. Merck WO017047 (2010).
111. Merck WO065384 (2010).
112. Sunesis Pharmaceuticals WO005457 (2008).
113. Merck WO127754 (2010).
114. Merck & Co. WO054941 (2009).
115. Merck WO006567 (2011).
116. Boehringer Ingelheim WO107444 (2008).
117. Boehringer Ingelheim WO007114 (2010).
118. Boehringer Ingelheim WO007116 (2010).
119. Schering AG US07105563 (2006).
120. GlaxoSmithKline WO019637 (2010).
121. GlaxoSmithKline WO059658 (2010).
122. GlaxoSmithKline WO120854 (2010).
123. Novartis Vaccines & Diagnostics Inc. WO117607 (2007).
124. Novartis WO153313 (2009).
125. Novartis WO079988 (2008).
126. Sunesis & Biogen WO044157 (2011).
127. Wyeth WO109599 (2008).
128. Wyeth WO109613 (2008).
129. The Ohio State University Research Foundation US0111799 (2009).
130. Universities of London and Bath WO064559 (2011).
131. Eli Lilly and Co. 041953 (2005).
132. AstraZeneca UK Ltd. WO106326 (2006).
133. Schering AG US0186118A1 (2004).
134. Boehringer Ingelheim Intl. GmbH WO003766 (2008).
135. OSI Pharmaceuticals Inc. WO084667 (2007).
136. Merck Patent GmbH WO079826 (2007).
137. Novartis AG-054238 (2008).
138. Novartis AG WO034600 (2008).
139. SGX Pharmaceuticals Inc. WO015124 (2006).
140. IRM LLC, The Scripps Research Institute WO093812 (2004).
141. Vernalis Cambridge Ltd. WO087707 (2004).
142. Vernalis Cambridge Ltd. WO108136 (2004).
143. Vernalis R&D Ltd. WO134318 (2006).
144. Vertex Pharmaceuticals Inc. WO064397 (2003).
145. Vertex Pharmaceuticals Inc. WO046120 (2004).
146. Vertex Pharmaceuticals WO050249 (2006).
147. Wyeth US0135429 (2007).
148. Phosphosites GmbH EP-1486488-A1 (2004).